Calreticulin inhibits the MEK1,2-ERK1,2 pathway in α1-adrenergic receptor/Gh-stimulated hypertrophy of neonatal rat cardiomyocytes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 1, 2003, Pages 101-107

  Lee, Kyung Hye ^a   Lee, Namho ^b   Lim, Soyeon ^a   Jung, Heekyung ^a   Ko, Young Guk ^a   Park, Hyun Young ^a   Jang, Yangsoo ^a   Lee, Hakbae ^c   Hwang, Ki Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Calreticulin; ERKs; Gh; Hypertrophy; Neonatal rat cardiomyocyte

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALRETICULIN; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; NORADRENALIN; PRAZOSIN; PROPRANOLOL; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; PHENOTYPE; RAT; SIGNAL TRANSDUCTION;

EID: 0344837797     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00006-2     Document Type: Article

References (34)

1. 1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33:2001;779-787.
2. 1- and β-adrenoceptors. Circulation. 95:1997;1260-1268.
3. Pinson A., Schluter K.D., Zhou X.J., Schwarz P., Kessler I.G., Piper H.M. α- and β-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 25:1993;477-490.
4. 1-Adrenergic receptor subtypes: molecular structure, function, and signalling. Circ. Res. 78:1996;737-739.
5. T. Iismaa, T.J. Biden, J. Shine, G-Protein-Coupled Receptors, CRC Press, New York, 1994.
6. 1-adrenergic receptors is mediated by the α subunits of Gq family. J. Biol. Chem. 267:1992;25798-25802.
7. 11 alpha. Am. J. Physiol. 275:1998;C636-645.
8. h: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 264:1994;1593-1596.
9. h (transglutaminase II) with phospholipase C. J. Biol. Chem. 270:1995;27058-27062.
10. h in the failing human heart. Circulation. 94:1996;718-726.
11. Feng J.F., Readon M., Yadav S.P., Im M.J. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry. 38:1999;10743-10749.
12. Yamazaki T., Komuro I., Shiojima I., Yazaki Y. The molecular mechanism of cardiac hypertrophy and failure. Ann. N. Y. Acad. Sci. 874:1999;38-48.
13. Hefti M.A., Harder B.A., Eppenberger H.M., Schaub M.C. Signaling pathways in cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol. 29:1997;2873-2892.
14. Yamazaki T., Yazaki Y. Molecular basis of cardiac hypertrophy. Z. Kardiol. 89:2000;1-6.
15. Page C., Doubell A.F. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol. Cell. Biochem. 157:1996;49-57.
16. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:1998;725-746.
17. 2 expressed in the heart. J. Mol. Cell. Cardiol. 29:1997;2095-2106.
18. 2 toxicity. Am. J. Physiol. 276:1999;H167-H175.
19. Glennon P.E., Kaddoura S., Sale E.M., Sale G.J., Fuller S.J., Sugden P.H. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ. Res. 78:1996;954-961.
20. Thorburn J., Frost J.A., Thorburn A. Mitogen-activating protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126:1994;1565-1572.
21. Yamazaki T., Komuro I., Kudoh S., Zou Y., Shiojima I., Mizuno T., Takano H., Hiroi Y., Ueki K., Tobe K., Kadowaki T., Nagai R., Yazaki Y. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 96:1995;438-446.
22. 1- and β-adrenergic receptor interaction. Circ. Res. 56:1985;884-889.
23. 1- and β-adrenoceptors. Circulation. 95:1997;1260-1268.
24. Hwang K.C., Lee K.H., Jang Y.S. Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells. J. Steroid Biochem. Mol. Biol. 80:2002;85-90.
25. 1-Adrenergic receptor regulation: basic science and clinical implications. Pharmacol. Ther. 88:2000;281-309.
26. q-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;17148-17153.
27. 1-adrenoceptor: inotropic effect and physiologic and pathologic implications. Life Sci. 60:1997;1305-1318.
28. Inglese J., Koch W.J., Touhara K., Lefkowitz R.J. G beta gamma interactions with pH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20:1995;151-156.
29. Blumer K.J., Johnson G.L. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:1994;236-240.
30. Bogoyevitch M.A., Andersson M.B., Gillespie-Brown J., Clerk A., Glennon P.E., Fuller S.T., Sugden P.H. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314:1996;115-121.
31. h: a GTP-binding protein with transglutaminase activity and receptor signalling. Science. 264:1994;1593-1596.
32. q interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 280:1998;574-577.
33. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem. J. 344:1999;281-292.
34. Feng J.F., Readon M., Yadav S.P., Im M.J. Calreticulin down-regulates GTP binding and transglutaminase activities of transglutaminase II. Biochemistry. 38:1999;10743-10749.